BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18410837)

  • 1. Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium.
    Bebarta VS; King JA; McDonough M
    Am J Emerg Med; 2008 May; 26(4):519.e1-2. PubMed ID: 18410837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    Clark DW; Strandell J
    Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia.
    Kamijo Y; Soma K; Asari Y; Ohwada T
    Vet Hum Toxicol; 1999 Dec; 41(6):381-3. PubMed ID: 10592946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced gastric cancer with rhabdomyolysis].
    Hasegawa H; Naitoh H; Tsuchihashi H; Hanasawa K; Okada K; Kuwahara K
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2921-4. PubMed ID: 21160271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
    Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
    Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor-induced acute interstitial nephritis.
    Härmark L; van der Wiel HE; de Groot MC; van Grootheest AC
    Br J Clin Pharmacol; 2007 Dec; 64(6):819-23. PubMed ID: 17635502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report.
    van der Zalm IJB; Tobé TJM; Logtenberg SJJ
    J Med Case Rep; 2020 Jun; 14(1):83. PubMed ID: 32594911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacovigilance study of association between proton-pump inhibitors and rhabdomyolysis event based on FAERS database.
    Sun Y; Zhang A; Zuo M; Chen J; Zhu L
    J Gastroenterol Hepatol; 2024 Feb; 39(2):289-296. PubMed ID: 37961012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia.
    Issa I; Skov J; Falhammar H; Calissendorff J; Lindh JD; Mannheimer B
    Eur J Clin Pharmacol; 2023 Jan; 79(1):71-77. PubMed ID: 36380227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uses of proton pump inhibitors and serum potassium levels.
    Gau JT; Heh V; Acharya U; Yang YX; Kao TC
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):865-71. PubMed ID: 19557730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole-associated rhabdomyolysis.
    Tanaka K; Nakada TA; Abe R; Itoga S; Nomura F; Oda S
    Crit Care; 2014 Jul; 18(4):462. PubMed ID: 25184508
    [No Abstract]   [Full Text] [Related]  

  • 15. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse.
    Reimer C; Bytzer P
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1182-8. PubMed ID: 20664352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe hypomagnesaemia due to proton pump inhibitor use].
    van den Berg S; Scheer MLJ; Holman ND
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent rhabdomyolysis associated with polydipsia-induced hyponatremia - a case report and review of the literature.
    Strachan P; Prisco D; Multz AS
    Gen Hosp Psychiatry; 2007; 29(2):172-4. PubMed ID: 17336668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors and Risk of Rhabdomyolysis.
    Duncan SJ; Howden CW
    Drug Saf; 2017 Jan; 40(1):61-64. PubMed ID: 27838824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New frequent adverse reaction of PPI in older adults: mild hyponatremia].
    Peyro Saint Paul L; Martin J; Buon M; Gaillard C; Fedrizzi S; Mosquet B; Coquerel A
    Therapie; 2014; 69(2):157-62. PubMed ID: 24926634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichenoid drug eruption.
    Brauer J; Votava HJ; Meehan S; Soter NA
    Dermatol Online J; 2009 Aug; 15(8):13. PubMed ID: 19891921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.